{"id":61978,"date":"2024-11-25T12:05:01","date_gmt":"2024-11-25T12:05:01","guid":{"rendered":"https:\/\/english.saigonbiz.com.vn\/2024\/11\/25\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/"},"modified":"2024-11-25T12:05:01","modified_gmt":"2024-11-25T12:05:01","slug":"rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/","title":{"rendered":"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction"},"content":{"rendered":"<div>\n<p align=\"justify\"><strong>ALACHUA, Fla., November 25, 2024<\/strong> \u2013 RTI Surgical (&#8220;RTI&#8221;), a leading CDMO pushing the boundaries of innovation and tissue engineering to address patient needs in regenerative medicine, today announced the enrollment of the first patient in ADMIRE (Acellular Dermal Matrix Investigation in Breast Reconstruction). This Investigational Device Exemption study is designed to confirm the safety and effectiveness of Cortiva\u00ae Allograft Dermis (ADM) in implant-based breast reconstruction.<\/p>\n<p align=\"justify\">Cortiva\u00ae ADM, commonly used in soft tissue repair, is a graft derived from human dermis, processed using RTI\u2019s proprietary Tutoplast\u00ae Tissue Sterilization Process. ADMIRE is a prospective, multi-center, dual-arm, non-randomized clinical study which will support RTI\u2019s pre-market approval application for a breast reconstruction indication. The study will enroll 467 female patients undergoing two-stage breast reconstruction using the pre-pectoral technique and was developed with advice and input from the FDA.<\/p>\n<p align=\"justify\"><strong>Amanda LoGuidice PhD, Chief Scientific Officer of RTI Surgical, said<\/strong>: <em>\u201cOur goal is to provide surgeons and patients with clinically validated options that meet the individual needs of those undergoing breast reconstruction as part of breast cancer treatment. This study, the first allograft IDE in this field, underscores our commitment to advancing patient care through innovative, evidence-based solutions. We are eager to progress through this trial and deliver solutions that we believe will improve outcomes for patients.\u201d<\/em><\/p>\n<p align=\"justify\"><strong>Dr. Suhail A. Kanchwala, National Principal Investigator for the study and Associate Professor of Surgery at the University of Pennsylvania, added: <\/strong><em>\u201cI am excited to lead this important clinical trial as the National Principal Investigator. This study represents a significant step forward in advancing patient care. With RTI Surgical taking a bold step as a leader in this space, our collaborative efforts will generate meaningful data that can shape the future of breast reconstruction and, hopefully, will set new standards in improving patient outcomes and quality of life.\u201d<\/em><\/p>\n<p align=\"center\"><strong>ENDS<\/strong><\/p>\n<p><strong>About RTI Surgical<\/strong><\/p>\n<p align=\"justify\">RTI Surgical (RTI) is a leading Contract Development and Manufacturing Organization (CDMO) pushing the boundaries of innovation and tissue engineering to meet patient needs in regenerative medicine. We are expert partners to Original Equipment Manufacturers (OEMs), working with them to identify clinical problems\u00a0and\u00a0develop customized solutions that promote healing, accelerate recovery, and help prevent complications. Using our extensive portfolio of biological materials, we focus on specialized clinical segments, including plastic and reconstructive surgery, sports medicine and orthopedics, cardiac, and neuro and spine surgery. Headquartered in Alachua, Florida, RTI has facilities in the United States, Europe and New Zealand. For more information, visit<\/p>\n<p align=\"justify\">https:\/\/www.rtix.com<\/p>\n<p align=\"justify\">For media enquiries please contact:<\/p>\n<p align=\"justify\"><strong>RTI Surgical<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Amelia Bell\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/>Tel: +1 386.418.5100\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=e8RhJoLwmrZn0lUjriKeN1Rf-Czj2fY8j8Vk7j__lYMaGjNNvCrvftyK_E2jEm848K_8EDzUQXpsbx0F9AWyPMIXeqy5-ciTDKC8vcMdetkVYZ3uFnIAmuEEYhrOpnfJ3L7bRAZ1wKGIrrHYCuMyh7tIb2j-PJ-VjdPIuwUzsy2-5ctRJqrBCzVWOpxzNdxv7SdzQtf8hMHz46DVBiE43Q==\" rel=\"nofollow\" target=\"_blank\" title=\"abell@rtix.com\">abell@rtix.com<\/a><\/p>\n<p align=\"justify\"><strong>ICR Healthcare<\/strong>\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XqFNJMS1OPUMYPUjwVKNUpk-ymnfDi7iNHvJZ5QU1K73OL1tVBFYTjZ_ZUxId8zMzwZZMMqMV3tlcuOsA9OFcHbR1c4zigs_my_j9u7jxsxkjaqz1RGyPfVR-S34gULNjfkY0FP7fj7XTBHIfbFV4wiCqTLvZb5SCBHpPj_prXSYY2YU3jROiC1Rfe58Wg8aKskSH2dEnxagHCraxXXK2qfLFZ3kWu5sWwgxKLvIP7Tj58N95MzM3OY9aNNemUxpWPq8ljtP2wXWr7lCvUtSGoJ6THAgfdY3-rE1LlEEr9VSpLft6qpzmovvzGzoBzSb\" rel=\"nofollow\" target=\"_blank\" title=\"rtisurgical@icrhealthcare.com\">rtisurgical@icrhealthcare.com<\/a>\u00a0<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/ZTlhMjE2MjItODdhYy00ZmFlLTlkNzYtODVmY2E4Y2ExNmExLTcwMDAyNDc2NQ==\/tiny\/RTI-Surgical.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>ALACHUA, Fla., November 25, 2024 \u2013 RTI Surgical (&#8220;RTI&#8221;), a leading CDMO pushing the boundaries of innovation and tissue engineering to address patient needs in regenerative medicine, today announced the enrollment of the first patient in ADMIRE (Acellular Dermal Matrix Investigation in Breast Reconstruction). This Investigational Device Exemption study is designed to confirm the safety [&#8230;]\n","protected":false},"author":1,"featured_media":61979,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-61978","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction\" \/>\n<meta property=\"og:description\" content=\"ALACHUA, Fla., November 25, 2024 \u2013 RTI Surgical (&#8220;RTI&#8221;), a leading CDMO pushing the boundaries of innovation and tissue engineering to a\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-11-25T12:05:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/RTI-Surgical.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1\" \/>\n\t<meta property=\"og:image:height\" content=\"1\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction\",\"datePublished\":\"2024-11-25T12:05:01+00:00\",\"dateModified\":\"2024-11-25T12:05:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/\"},\"wordCount\":445,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/\",\"name\":\"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2024-11-25T12:05:01+00:00\",\"dateModified\":\"2024-11-25T12:05:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/","og_locale":"en_US","og_type":"article","og_title":"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction","og_description":"ALACHUA, Fla., November 25, 2024 \u2013 RTI Surgical (&#8220;RTI&#8221;), a leading CDMO pushing the boundaries of innovation and tissue engineering to a","og_url":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2024-11-25T12:05:01+00:00","og_image":[{"width":1,"height":1,"url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2024\/11\/RTI-Surgical.png","type":"image\/png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction","datePublished":"2024-11-25T12:05:01+00:00","dateModified":"2024-11-25T12:05:01+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/"},"wordCount":445,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/","url":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/","name":"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2024-11-25T12:05:01+00:00","dateModified":"2024-11-25T12:05:01+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/rti-surgical-announces-first-patient-enrolled-in-investigational-device-exemption-ide-for-cortiva-allograft-dermis-in-breast-reconstruction\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva\u00ae Allograft Dermis in Breast Reconstruction"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61978","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=61978"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/61978\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/61979"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=61978"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=61978"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=61978"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}